Abstract: Compounds and methods to treat or prevent CNS diseases, such as Alzheimer's disease and brain injury inflammation, are disclosed herein. The compounds are soluble epoxide hydrolase (sEH) inhibitors and have improved physical properties, blood-brain-barrier (BBB) penetration and long drug-target residence time. Pharmaceutical compositions and kits comprising the compounds are also disclosed herein.
Type:
Application
Filed:
April 12, 2024
Publication date:
September 5, 2024
Applicant:
Board of Trustees of Michigan State University
Inventors:
Edmund L. ELLSWORTH, Kin Sing Stephen LEE
Abstract: The invention is directed to novel sBCMA variants and sBCMA variant—Fc fusion proteins, polynucleotides encoding the sBCMA variants and/or sBCMA variant—Fc fusion proteins, methods of making the sBCMA variants and/or sBCMA variant—Fc fusion proteins, and methods of using compositions comprising the sBCMA variants and/or sBCMA variant—Fc fusion proteins, for example, in treating diseases such as tumors/cancers, immunoregulatory disorders, etc.
Type:
Application
Filed:
August 11, 2021
Publication date:
September 5, 2024
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Amato J. Giaccia, Yu Miao, Kaushik Thakkar, Kazue Mizuno
Abstract: Use of a rAAV3B vector to deliver gene products to human hepatocytes is described. The rAAV3B vectors achieve high levels of transduction even in the presence of pre-existing immunity to AAV8 or AAVrh10. Compositions and treatment regimens are described. Also provided are rAAV engineered to facilitate purification and methods of purifying the AAV.
Type:
Application
Filed:
October 27, 2023
Publication date:
September 5, 2024
Applicant:
The Trustees of the University of Pennsylvania
Abstract: A partner-assisted artificial selection (PAAS) approach, in which an assisting population acts as an intermediate to create feedback from the function of interest to the fitness of the producer. The selection for improved growth in this approach successfully leads to improved degradation performance, even in the presence of other sources of stochasticity. Successful implementation of PAAS evolves improved functions of interest such as detoxification of harmful compounds.
Type:
Application
Filed:
May 3, 2023
Publication date:
September 5, 2024
Applicant:
The Trustees of Boston College
Inventors:
Babak Momeni, Marco Zaccaria, Natalie Sandlin
Abstract: Programmable bacterial cells that comprise a gene that regulates capsular polysaccharide nanoencapsulation of the bacterium linked to an exogenous promoter, wherein expression of the gene and the nanoencapsulation can be programmed or controlled by an external modulator of the exogenous promoter and related compositions and methods.
Type:
Application
Filed:
October 31, 2023
Publication date:
September 5, 2024
Applicant:
The Trustees of Columbia University in the City of New York
Inventors:
Tal DANINO, Kam LEONG, Tetsuhiro HARIMOTO, Jaeseung HAHN
Abstract: An exemplary system, method and computer-accessible medium for harmonizing neuromelanin (NM) data using combat directly on a NM database or using combat generated coefficients to harmonize future data can include, for example, receiving imaging information of a brain of the patient(s), from one MRI scanner, receiving imaging information of a brain of the patient(s), from a second MRI scanner and using combat to harmonize the data between scanners against a reference dataset. The Neuromelanin (NM) concentration of the patient(s) can then be determined based on the harmonized data. The NM concentration can be determined using a voxel-wise analysis procedure. The voxel-wise analysis procedure can be used to determine a topographical pattern(s) within a substantia nigra (SN) of the brain of the patient(s).
Type:
Grant
Filed:
March 11, 2022
Date of Patent:
September 3, 2024
Assignees:
Terran Biosciences Inc., The Trustees of Columbia University in the City of New York, The Research Foundation for Mental Hygiene, Inc.
Inventors:
Samuel Clark, Kenneth Wengler, Guillermo Horga Hernandez
Abstract: A polyacrylamide-based copolymer reduces or prevents aggregation of biologic molecules including proteins, peptides, and nucleic acids, and lipid-based vehicles such as liposomes, lipid nanoparticles, polymerosomes, and micelles, in aqueous formulations at hydrophobic interfaces, thereby increasing the thermal stability of the molecules in the formulation. Methods and compositions comprising the copolymer and a protein or the copolymer and insulin can be used for treating conditions including diabetes.
Type:
Grant
Filed:
October 17, 2023
Date of Patent:
September 3, 2024
Assignee:
The Board of Trustees of the Leland Stanford Junior Univeristy
Inventors:
Eric A. Appel, Caitlin Maikawa, Joseph L. Mann
Abstract: Mechanisms for proving the correctness of software on relaxed memory hardware are provided, the mechanisms comprising: receiving a specification, a hardware model, and an implementation for the software to be executed on the relaxed memory hardware; evaluating the software using a sequentially consistent hardware model; evaluating the software using a relaxed memory hardware model and at least one of the following conditions: a data-race-free (DRF)-kernel condition; a no-barrier-misuse condition; a memory-isolation condition; a transactional-page-table condition; a write-once-kernel-mapping condition; and a weak-memory-isolation condition; and outputting an indication of whether the software is correct based on the evaluating the software using the sequentially consistent hardware model and the evaluating the software using the relaxed memory hardware model.
Type:
Grant
Filed:
July 14, 2021
Date of Patent:
September 3, 2024
Assignee:
The Trustees of Columbia University in the City of New York
Abstract: Systems and methods for global positioning satellite (GPS)/global navigation satellite system (GNSS) based real time global asset tracking are described. In an embodiment provides a system for real time, fast, global asset tracking, the system includes: a server with a processor, a memory, and a network interface, wherein the memory includes a tracking application, where the tracking application directs the processor to: receive a message including specific data from a tag; determine a time search window based on the message received from the tag; perform an initial position search; perform calculations for position and time, utilizing the time search window, the initial position search and satellite ephemeris information; and display a position information of the tag.
Type:
Grant
Filed:
May 22, 2023
Date of Patent:
September 3, 2024
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Barbara Ann Block, Sherman C. Lo, David S. De Lorenzo, Yu-Hsuan Chen, Per K. Enge
Abstract: The present disclosure generally pertains to devices and methods for generating thrust in vehicles, for instance in space applications. A heaterless, insertless hollow cathode utilizes AC and pulsed DC electric fields to ionize the propellant gas and generate a plasma plume. The cathode uses an argon microplasma generated in a quartz tube with a tungsten filament and brass ion collector. Free electrons are then drawn from the plasma plume and supplied to a thruster engine.
Type:
Grant
Filed:
October 5, 2018
Date of Patent:
September 3, 2024
Assignee:
The Board of Trustees of the University of Alabama, for and on behalf of the University of Alabama in Huntsville
Abstract: Ultrasound imaging and therapy with the same array of capacitive micromachined ultrasonic transducers is provided. The electronics includes a per-pixel switch for each transducer element. The switches provide an imaging mode driven completely by on-chip electronics and a therapy mode where off-chip pulsers provide relatively high voltages to the transducer elements.
Type:
Grant
Filed:
June 19, 2023
Date of Patent:
September 3, 2024
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Abstract: The present invention provides compositions and methods for inhibiting ACSS2 for modulating histone acetylation or for treating or preventing a neurological disease or disorder.
Type:
Grant
Filed:
September 26, 2018
Date of Patent:
September 3, 2024
Assignee:
The Trustees of the University of Pennsylvania
Inventors:
Philipp Mews, Shelley L Berger, Jeffrey D. Winkler, Andrew Glass, Simon David Peter Baugh
Abstract: A nanoparticle composition is provided. The nanoparticle composition includes a plurality of nanoparticles, each nanoparticle of the plurality having a core including tantalum oxide, and a covalent coating covalently bound to the core. The covalent coating includes a surface modifier selected from the group consisting of (3-aminopropyl)trimethoxy silane (APTMS), (3-aminopropyl)triethoxy silane (APTES), APTMS-methoxy-poly(ethylene-glycol)-succinimidyl glutarate (APTMS-m-PEG-glutarate), APTES-methoxy-poly(ethylene-glycol)-succinimidyl glutarate (APTES-m-PEG-glutarate), 2-[methoxy (polyethyleneoxy)-9-12-propyl] trimethoxysilane (PEG-Silane), hexadecyltriethoxy silane, and combinations thereof. Methods of synthesizing and using the nanoparticle composition are also provided.
Type:
Grant
Filed:
July 6, 2021
Date of Patent:
September 3, 2024
Assignee:
Board of Trustees of Michigan State University
Abstract: Provided herein are systems for determining a stretch condition of a tissue and assessing the stiffness of the tissue. Also provided herein are methods for using the systems for measuring stiffness of a tissue, assessing the effect of an agent on a tissue, and identifying subjects having a disease or disorder associated with increased or decreased stiffness of a tissue.
Type:
Grant
Filed:
June 16, 2023
Date of Patent:
September 3, 2024
Assignees:
Trustees of Boston University, Boston (MA), Beth Israel Deaconess Medical Center, Inc.
Inventors:
Bela Suki, Jae Hun Kim, Joseph Hall, Ramaswamy Krishnan, Niccole Schaible
Abstract: Disclosed herein, are methods of detecting multiple sclerosis in a subject by measuring relative abundances of multiple oral microbiota in sample. Also, disclosed herein are methods of treatment and prophylaxis of MS.
Type:
Grant
Filed:
April 7, 2022
Date of Patent:
September 3, 2024
Assignees:
The United States Government As Represented By The Department Of Veterans Affairs, The Board Of Trustees Of The University Of Illinois
Abstract: Polypeptide products, methods, pharmaceutical compositions, and kits are provided for treating a subject exposed to, or at risk for exposure to, C. difficile microbial pathogens and toxin B produced by C. difficile (TcdB) pathogens. The methods, compositions and kits include a single domain, anti-TedB VHH polypeptide (antibody), or toxin B binding portion thereof, that specifically binds to and/or neutralizes TedB and treats or prevents illness and disease associated with C. difficile infection and TedB intoxication. The anti-TcdB VHHs, or toxin B binding portion thereof, may be recombinantly produced.
Abstract: The present invention provides a compound having the structure: wherein R1, R2, R3, R4, and R5 are each independently H, halogen, CF3 or C1-C4 alkyl; R6 is H, OH, or halogen; B is a substituted or unsubstituted heterobicycle, pyridazine, pyrazole, pyrazine, thiadiazole, or triazole, wherein the heterobicycle is other than chloro substituted indole; and the pyrazole, when substituted, is substituted with other than trifluoromethyl, or a pharmaceutically acceptable salt thereof.
Type:
Application
Filed:
February 9, 2024
Publication date:
August 29, 2024
Applicant:
The Trustees of Columbia University in the City of New York
Inventors:
Konstantin Petrukhin, Christopher Cioffi, Graham Johnson, Nicoleta Dobri, Emily Freeman, Ping Chen, Michael Conlon, Lei Zhu
Abstract: In an embodiment, the present disclosure pertains to a method of changing the glass transition temperature of a polymer. In some embodiments, the polymer includes at least one hydrazone-containing compound. In general, the methods of the present disclosure include one or more of the following steps of: (1) applying light to the polymer; and (2) thereby changing the glass transition temperature of the polymer. In another embodiment, the present disclosure pertains to a polymer having a light-adjustable glass transition temperature. In some embodiments, the polymer includes at least one hydrazone-containing compound.
Type:
Application
Filed:
April 18, 2024
Publication date:
August 29, 2024
Applicant:
Trustees of Dartmouth College
Inventors:
Ivan Abrahamian, Sirun Yang, Laura L. Jeliazkov, Jared D. Harris